Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Clinical use of nefazodone in major depression: a 6-year perspective.

Publication ,  Journal Article
Schatzberg, AF; Prather, MR; Keller, MB; Rush, AJ; Laird, LK; Wright, CW
Published in: J Clin Psychiatry
2002

Duke Scholars

Published In

J Clin Psychiatry

ISSN

0160-6689

Publication Date

2002

Volume

63 Suppl 1

Start / End Page

18 / 31

Location

United States

Related Subject Headings

  • Triazoles
  • Sleep
  • Selective Serotonin Reuptake Inhibitors
  • Secondary Prevention
  • Randomized Controlled Trials as Topic
  • Psychiatry
  • Piperazines
  • Meta-Analysis as Topic
  • Humans
  • Hospitalization
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Schatzberg, A. F., Prather, M. R., Keller, M. B., Rush, A. J., Laird, L. K., & Wright, C. W. (2002). Clinical use of nefazodone in major depression: a 6-year perspective. J Clin Psychiatry, 63 Suppl 1, 18–31.
Schatzberg, Alan F., Maureen R. Prather, Martin B. Keller, A John Rush, Lyle K. Laird, and Clinton W. Wright. “Clinical use of nefazodone in major depression: a 6-year perspective.J Clin Psychiatry 63 Suppl 1 (2002): 18–31.
Schatzberg AF, Prather MR, Keller MB, Rush AJ, Laird LK, Wright CW. Clinical use of nefazodone in major depression: a 6-year perspective. J Clin Psychiatry. 2002;63 Suppl 1:18–31.
Schatzberg, Alan F., et al. “Clinical use of nefazodone in major depression: a 6-year perspective.J Clin Psychiatry, vol. 63 Suppl 1, 2002, pp. 18–31.
Schatzberg AF, Prather MR, Keller MB, Rush AJ, Laird LK, Wright CW. Clinical use of nefazodone in major depression: a 6-year perspective. J Clin Psychiatry. 2002;63 Suppl 1:18–31.

Published In

J Clin Psychiatry

ISSN

0160-6689

Publication Date

2002

Volume

63 Suppl 1

Start / End Page

18 / 31

Location

United States

Related Subject Headings

  • Triazoles
  • Sleep
  • Selective Serotonin Reuptake Inhibitors
  • Secondary Prevention
  • Randomized Controlled Trials as Topic
  • Psychiatry
  • Piperazines
  • Meta-Analysis as Topic
  • Humans
  • Hospitalization